Literature DB >> 29764969

Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.

Wilson Nadruz1,2, Erin West1, Morten Sengeløv1, Gabriela L Grove1, Mário Santos3, John D Groarke1, Daniel E Forman4, Brian Claggett1, Hicham Skali1, Anju Nohria1, Amil M Shah1.   

Abstract

OBJECTIVE: This study compared the clinical features, cardiac structure and function evaluated by echocardiography, cardiopulmonary response to exercise and long-term clinical outcomes between patients with heart failure (HF) induced by cancer therapy (CTHF) and heart failure not induced by cancer therapy (NCTHF).
METHODS: We evaluated 75 patients with CTHF and 894 with NCTHF who underwent clinically indicated cardiopulmonary exercise testing, and followed these individuals for a median of 4.5 (3.0-5.8) years, during which 187 deaths and 256 composite events (death, heart transplantation and left ventricular (LV) assistant device implantation) occurred.
RESULTS: Compared with NCTHF, patients with CTHF were younger, with lower prevalence of cardiovascular comorbidities, higher LV ejection fraction (LVEF), but similar global longitudinal strain. LV diastolic function (higher E/e' ratio) and compliance (higher end-diastolic pressure/LV end-diastolic volume index ratio) were worse in CTHF and were both associated with adverse outcomes. Despite a favourable clinical profile, peak VO2 and VE/VCO2 slope were similarly impaired in CTHF and NCTHF. In multivariable Cox regression analysis including clinical characteristics, cardiopulmonary exercise testing variables and LVEF, CTHF was associated with a significantly higher risk of death (HR 2.64; 95% CI 1.53 to 4.55; p=0.001) and composite events (HR 1.79; 95% CI 1.10 to 2.91; p=0.019) compared with NCTHF.
CONCLUSIONS: CTHF is characterised by a distinct clinical profile, better LVEF but worse LV diastolic properties, and similarly impaired global longitudinal strain, functional capacity and ventilatory efficiency. Accounting for differences in clinical characteristics, CTHF was associated with worse long-term prognosis than NCTHF. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cancer; cardiopulmonary exercise testing; diastolic function; heart failure; strain

Mesh:

Substances:

Year:  2018        PMID: 29764969      PMCID: PMC7333864          DOI: 10.1136/heartjnl-2018-313234

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  A Matched Cohort Study of Patients With End-Stage Heart Failure from Anthracycline-Induced Cardiomyopathy Requiring Advanced Cardiac Support.

Authors:  Garry R Thomas; Michael A McDonald; Jennifer Day; Heather J Ross; Diego H Delgado; Filio Billia; Jagdish W Butany; Vivek Rao; Eitan Amir; Philippe L Bedard; Paaladinesh Thavendiranathan
Journal:  Am J Cardiol       Date:  2016-08-23       Impact factor: 2.778

Review 3.  Advanced heart failure therapies for patients with chemotherapy-induced cardiomyopathy.

Authors:  Guilherme H Oliveira; Marwan Y Qattan; Sadeer Al-Kindi; Soon J Park
Journal:  Circ Heart Fail       Date:  2014-11       Impact factor: 8.790

4.  Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.

Authors:  Gregory T Armstrong; Vijaya M Joshi; Kirsten K Ness; Thomas H Marwick; Nan Zhang; DeoKumar Srivastava; Brian P Griffin; Richard A Grimm; James Thomas; Dermot Phelan; Patrick Collier; Kevin R Krull; Daniel A Mulrooney; Daniel M Green; Melissa M Hudson; Leslie L Robison; Juan Carlos Plana
Journal:  J Am Coll Cardiol       Date:  2015-06-16       Impact factor: 24.094

5.  Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Authors:  Amil M Shah; Brian Claggett; Nancy K Sweitzer; Sanjiv J Shah; Inder S Anand; Eileen O'Meara; Akshay S Desai; John F Heitner; Guichu Li; James Fang; Jean Rouleau; Michael R Zile; Valetin Markov; Vyacheslav Ryabov; Gilmar Reis; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-08-13       Impact factor: 8.790

6.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  J Am Soc Echocardiogr       Date:  2014-09       Impact factor: 5.251

7.  Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.

Authors:  Amil M Shah; Brian Claggett; Nancy K Sweitzer; Sanjiv J Shah; Inder S Anand; Li Liu; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circulation       Date:  2015-06-30       Impact factor: 29.690

8.  Predicted values for clinical exercise testing.

Authors:  J E Hansen; D Y Sue; K Wasserman
Journal:  Am Rev Respir Dis       Date:  1984-02

9.  Cardiac function in Wilms' tumor survivors.

Authors:  K Sorensen; G Levitt; D Sebag-Montefiore; C Bull; I Sullivan
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

Review 10.  Chronotropic incompetence: causes, consequences, and management.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 39.918

View more
  8 in total

Review 1.  The use of cardiovascular magnetic resonance as an early non-invasive biomarker for cardiotoxicity in cardio-oncology.

Authors:  Matthew K Burrage; Vanessa M Ferreira
Journal:  Cardiovasc Diagn Ther       Date:  2020-06

2.  atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity.

Authors:  Yong Wang; Xiaoguang Lu; Xiaoping Wang; Qi Qiu; Ping Zhu; Lin Ma; Xiao Ma; Joerg Herrmann; Xueying Lin; Wei Wang; Xiaolei Xu
Journal:  Circ Res       Date:  2021-08-13       Impact factor: 23.213

Review 3.  Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'.

Authors:  Markus S Anker; Alessia Lena; Sara Hadzibegovic; Yury Belenkov; Jutta Bergler-Klein; Rudolf A de Boer; Alain Cohen-Solal; Dimitrios Farmakis; Stephan von Haehling; Teresa López-Fernández; Radek Pudil; Thomas Suter; Carlo G Tocchetti; Alexander R Lyon
Journal:  ESC Heart Fail       Date:  2018-12

Review 4.  Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance.

Authors:  Jin Jiang; Boyang Liu; Sandeep S Hothi
Journal:  Cardiol Res Pract       Date:  2022-02-27       Impact factor: 1.866

5.  Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular Mortality.

Authors:  Giosafat Spitaleri; Elisabet Zamora; German Cediel; Pau Codina; Evelyn Santiago-Vacas; Mar Domingo; Josep Lupón; Javier Santesmases; Crisanto Diez-Quevedo; Maria Isabel Troya; Maria Boldo; Salvador Altimir; Núria Alonso; Beatriz González; Antoni Bayes-Genis
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

6.  Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study.

Authors:  Husam Abdel-Qadir; Felicia Tai; Ruth Croxford; Peter C Austin; Eitan Amir; Oscar Calvillo-Argüelles; Heather Ross; Douglas S Lee; Paaladinesh Thavendiranathan
Journal:  Circ Heart Fail       Date:  2021-06-30       Impact factor: 8.790

Review 7.  The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview.

Authors:  Stephen Foulkes; Guido Claessen; Erin J Howden; Robin M Daly; Steve F Fraser; Andre La Gerche
Journal:  Front Cardiovasc Med       Date:  2020-03-10

8.  Influence of extracellular volume fraction on peak exercise oxygen pulse following thoracic radiotherapy.

Authors:  Justin M Canada; Elisabeth Weiss; John D Grizzard; Cory R Trankle; Leila Rezai Gharai; Franklin Dana; Leo F Buckley; Salvatore Carbone; Dinesh Kadariya; Anthony Ricco; Jennifer H Jordan; Ronald K Evans; Ryan S Garten; Benjamin W Van Tassell; W Gregory Hundley; Antonio Abbate
Journal:  Cardiooncology       Date:  2022-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.